These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1016 related articles for article (PubMed ID: 9529579)

  • 61. AgNOR, Ki-67 and PCNA expression in fibroepithelial tumours of the breast in correlation with morphological features.
    Barwijuk-Machała M; Musiatowicz B; Cylwik J; Reszeć J; Augustynowicz A
    Folia Morphol (Warsz); 2004 Feb; 63(1):133-5. PubMed ID: 15039920
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Morphometric evaluation of nucleolar organiser regions in reactive and neoplastic lymph node lesions.
    Arora B; Kumar S; Jain R
    J Indian Med Assoc; 2006 Jan; 104(1):16-8, 24. PubMed ID: 16850861
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Identification and assessment of nucleolar organizer regions (NORs)--technical problems.
    Zaczek M; Dabroś E; Maciejowski J; Szot W
    Pol J Pathol; 1994; 45(1):35-8. PubMed ID: 7513845
    [TBL] [Abstract][Full Text] [Related]  

  • 64. AgNOR and breast cancer. A study by image analysis.
    Ronco A; Larran J; López A; Vilches J
    Histol Histopathol; 1994 Apr; 9(2):309-13. PubMed ID: 8075491
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A critical evaluation of AgNOR counting in benign naevi and malignant melanoma.
    Orrell JM; Evans AT; Grant A
    J Pathol; 1991 Mar; 163(3):239-44. PubMed ID: 1707452
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Demonstration of the nucleolar organizer region by silver staining (AgNOR method) in research and in histopathological practice.
    Kodousek R; Dusek J
    Acta Univ Palacki Olomuc Fac Med; 1991; 131():9-37. PubMed ID: 1726500
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A comparative analysis of core needle biopsy and fine-needle aspiration cytology in the evaluation of palpable and mammographically detected suspicious breast lesions.
    Garg S; Mohan H; Bal A; Attri AK; Kochhar S
    Diagn Cytopathol; 2007 Nov; 35(11):681-9. PubMed ID: 17924407
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [AgNOR cytometry by means of automatic image analysis--a contribution to standardization].
    Rüschoff J; Plate KH; Contractor H; Schälte B; Thomas C
    Verh Dtsch Ges Pathol; 1990; 74():248-52. PubMed ID: 1708594
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Morphometry and digital AgNOR analysis in cytological imprints of benign, borderline and malignant serous ovarian tumours.
    Stemberger-Papić S; Stanković T; Vrdoljak-Mozetic D; Versa-Ostojić D; Krasević M; Stifter S; Audy-Jurković S
    Cytopathology; 2006 Dec; 17(6):382-9. PubMed ID: 17168922
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evaluation of fine needle aspiration and imprint cytology in the early diagnosis of breast lesions with histopathological correlation.
    Dutta SK; Chattopadhyaya A; Roy S
    J Indian Med Assoc; 2001 Aug; 99(8):421-3. PubMed ID: 11881855
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Quantitative study on nucleolar organizer regions in salivary gland tumours].
    Wang SZ
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1992 Mar; 27(2):74-6, 127. PubMed ID: 1337733
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Histochemical and histomorphometric studies on growth fractions in human breast carcinoma].
    Hahn J; Linhart W; Müller H; Renz S; Schneider M
    Verh Dtsch Ges Pathol; 1990; 74():262-7. PubMed ID: 1708598
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nucleolar organizer regions in laryngeal cancer.
    Klatka J; Skomra D
    Ann Univ Mariae Curie Sklodowska Med; 2001; 56():417-21. PubMed ID: 11977351
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Clinical significance of argyrophilic nucleolar organizer regions (AgNOR) and microvessel quantitation by staining for factor VIII-related antigen as prognostic indicators in stage I breast cancer].
    Ogawa Y; Chung YS; Nakata B; Takatsuka S; Maeda K; Sawada T; Kato Y; Yoshikawa K; Sowa M
    Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():66-70. PubMed ID: 7747994
    [TBL] [Abstract][Full Text] [Related]  

  • 75. AGNORS in skin lesions of cutaneous malignant lymphomas and pseudolymphomas.
    Qiu BS; Xu LZ; Kong JC; Chen HL; Tao LD
    Chin Med J (Engl); 1992 Jan; 105(1):30-3. PubMed ID: 1576867
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cytology. A valuable tool in prognostication of carcinoma breast.
    Singh UR; Sinha SK; Bhatia A; Gupta S
    Indian J Cancer; 1996 Dec; 33(4):187-91. PubMed ID: 9254998
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Argyrophilic nucleolar organizer regions in benign and malignant mesothelial lesions.
    Vacharadze K; Burkadze G; Turashvili G; Kiria N
    Georgian Med News; 2005 Nov; (128):91-3. PubMed ID: 16369075
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ki-67 and AgNOR proliferative markers as diagnostic adjuncts to fine needle aspiration cytology of thyroid follicular lesions.
    Mehrotra A; Goel MM; Singh K
    Anal Quant Cytol Histol; 2002 Aug; 24(4):205-11. PubMed ID: 12199321
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prognostic significance of nucleolar organizer regions (NORS) in malignant melanoma.
    Ronan SG; Farolan MJ; McDonald A; Manaligod JR; Das Gupta TK
    J Cutan Pathol; 1994 Dec; 21(6):494-9. PubMed ID: 7699115
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Study on diagnostic value of analyzing argyrophilic nucleolar organizer regions in benign and malignant pleural effusions].
    Jiang S; Zeng Z; Liao Z
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jan; 21(1):34-6. PubMed ID: 11263298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.